Company Description
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure.
The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.
It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services.
As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients.
Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States.
The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016.
DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Country | United States |
IPO Date | Oct 31, 1995 |
Industry | Medical - Care Facilities |
Sector | Healthcare |
Employees | 70,000 |
CEO | Javier J. Rodriguez |
Contact Details
Address: 2000 16th Street Denver, Colorado United States | |
Website | https://www.davita.com |
Stock Details
Ticker Symbol | DVA |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000927066 |
CUSIP Number | 23918K108 |
ISIN Number | US23918K1088 |
Employer ID | 51-0354549 |
SIC Code | 8090 |
Key Executives
Name | Position |
---|---|
Javier J. Rodriguez | Chief Executive Officer & Executive Director |
David Maughan | Chief Operating Officer |
Jessica Hergenreter | Chief People Officer |
Joel Ackerman | Chief Financial Officer & Treasurer |
Madhu Narasimhan | Chief Information Officer |
Christopher Michael Berry CPA | Group Vice President & Chief Accounting Officer |
James O. Hearty | Chief Compliance Officer |
Kathleen Alyce Waters | Chief Legal & Public Affairs Officer |
Misha Palecek | Chief Transformation Officer of U.S. Kidney Care Business |
Nic Eliason | Group Vice President of Investor Relations |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 05, 2024 | 4 | Filing |
Nov 27, 2024 | 4 | Filing |
Nov 19, 2024 | 4 | Filing |
Nov 19, 2024 | 4 | Filing |
Nov 19, 2024 | 4 | Filing |
Nov 19, 2024 | 4 | Filing |
Nov 19, 2024 | 4 | Filing |
Nov 19, 2024 | 4 | Filing |
Nov 19, 2024 | 4 | Filing |
Nov 19, 2024 | 4 | Filing |